---

Updates on the pathophysiology and therapies of chylous pleural effusion: A narrative review

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Elmukhtar Habas*, Kalifa Farfar, Almehdi Errayes, Gamal Alfitori, Hafedh Ghazouani, Ala Habas, Amnna Rayni, Aisha Aladab

Volume : 2, Issue : 3, Year : 2023

Article Page : 145-150

Suggest article by email

Abstract

Chylous pleural effusion (CPE) is a milky pleural fluid that contains high levels of proteins, cholesterol, triglycerides, or chylomicrons. The main cause of CPE is disruption of the thoracic duct caused by traumatic or non-traumatic causes. High triglyceride, cholesterol, and/or chylomicron levels confirm the diagnosis. Recognizing the chyle leak site and underlying etiology is critical to the management of this clinical condition. There is no specific consensus on chylothorax treatment. However, a multidisciplinary (medical, surgical, and oncological) team approach is recommended.

Keywords: Chylous pleural effusion, Epidemiology of chylous effusion, Pathophysiology pf chylous pleural effusion, Management of chylous pleural effusion

How to cite : Habas E, Farfar K, Errayes A, Alfitori G , Ghazouani H, Habas A, Rayni A, Aladab A, Updates on the pathophysiology and therapies of chylous pleural effusion: A narrative review. Yemen J Med 2023;2(3):145-150

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International, which allows others to remix, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.